Article
The microbiome in bronchiectasis
4 Sept 2019
Abstract excerpt
Bronchiectasis is increasing in prevalence worldwide, yet current treatments available are limited to those alleviating symptoms and reducing exacerbations. The pathogenesis of the disease and the inflammatory, infective and molecular drivers of disease progression are not fully understood, making the development of novel treatments challenging. Understanding the role bacteria play in disease progression has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
